Cleared Traditional

K791097 - CEPTORTRODE WITH CEPTOR HESIVE

K791097 is an FDA 510(k) clearance for CEPTORTRODE WITH CEPTOR HESIVE, manufactured by Med General. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 52-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1979
Decision
52d
Days
Class 2
Risk

K791097 is an FDA 510(k) clearance for the CEPTORTRODE WITH CEPTOR HESIVE. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Med General (Walker, US). The FDA issued a Cleared decision on August 3, 1979 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K791097

510(k) Number K791097 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 12, 1979
Decision Date August 03, 1979
Days to Decision 52 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 149d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 440
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K791097.
SHUR-PATCH TAPE PATCH
K803012 · Shur Medical Corp. · Dec 1980
TRU-PULSE PADS
K800117 · Ipco Corp. · Feb 1980
MEDTRONIC MOD. 3852 STERIL-ICE ELECTRODE
K792351 · Medtronic Vascular · Dec 1979
T.E.N.S.* SINGLE-USE ELECTRODE
K790850 · 3M Company · May 1979
ELECTRODES, STAODERM STERILE
K790542 · Staodynamics, Inc. · May 1979
ELECTRODE, ELECTROFLEX
K790316 · Andover Medical, Inc. · Mar 1979